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To the Editor,
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of 
extranodal B-cell lymphoma characterized by the growth of 
lymphoma cells within the lumina of small vessels. Two major 
patterns of clinical presentation have been recognized: the first 
is in European countries, with brain and skin involvement, and 
the second in Asian countries, where patients typically present 
with multiorgan failure, hepatosplenomegaly, pancytopenia, 
and hemophagocytic syndrome [1,2,3,4,5]. Primary IVLBCL of 
the gallbladder is exceedingly rare.
A 60-year-old male patient was admitted to the hospital with 
fever, abdominal pain, and weight loss. Physical examination 
showed an epigastric mass of approximately 4 cm in diameter 
and the absence of hepatosplenomegaly and lymphadenopathy. 
Laboratory tests revealed anemia (hemoglobin: 10 g/dL), with 
normal leukocytes and platelets. Peripheral smear showed 
normocytic-normochromic anemia without any abnormal cells. 
Increases in liver function tests were positive laboratory findings 
(aspartate aminotransferase: 240 U/L, alanine aminotransferase: 
240 U/L, alkaline phosphatase: 740 U/L, gamma-glutamyl 
transferase: 80 U/L, total bilirubin/direct bilirubin: 2.06/1.2 mg/
dL). Contrast-enhanced abdominal computerized tomography 
(CT) for further evaluation revealed a greater curvature-based 
mass of 8x5x5.5 cm in size, at the level of the distal gastric 
corpus, significantly narrowing the gastric lumen (Figures 1A 
and 1B). CT also showed hypodense areas in liver segments 
5 and 8 and gallbladder stones, the largest being 1.5 cm in 
diameter. Dynamic liver magnetic resonance imaging (MRI) 
was performed to characterize the liver lesions. MRI revealed 
calculous cholecystitis, choledocholithiasis, and a mass lesion of 
6.5x3 cm in size, thought to be based on the greater curvature at 
the corpus of the stomach. With no signs of distant metastasis, 
the patient primarily underwent both cholecystectomy and 
partial gastrectomy. Surgical biopsy of liver lesions revealed 
nonspecific inflammatory changes and no evidence of a tumor, 
while histologic examination confirmed a gastrointestinal 
stromal tumor (GIST) of the stomach. Histological analysis 
of the cholecystectomy material showed cells with irregular 
nuclear contours and open chromatin confined to small vessels, 
characteristic of the IVLBCL phenotype. These cells were strongly 
positive for CD20 stain (Figures 1C and 1D). Since intravascular 
infiltrations are easily missed on hematoxylin and eosin-stained 
sections, bone marrow and liver biopsy slides were also stained 
Figure 1. A, B) Axial computerized tomography image showing a 
greater curvature-based intraluminal gastric mass (white arrows), 
stones in the gallbladder (asterisk), and a vague hypodense area, 
which was proven to be caused by cholangitis, in segment 5 of 
the liver (black arrow). C) Intravascular B-cell lymphoma. The 
numerous dilated blood vessels were filled with large, atypical, 
centroblast-like lymphoid cells (hematoxylin and eosin, 400x). D) 
CD20-positive atypical lymphoid cells (400x).
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by CD20 and no evidence of intravascular lymphoma was 
found. A whole-body integrated positron electron tomography-
CT scan for tumor staging showed diffusely increased uptake 
of 18F-fludeoxyglucose in the liver (SUVmax: 7.0) and multiple 
lymph node lesions including the submandibular, preauricular, 
cervical, and jugular lymph nodes (SUVmax: 8.3). He was treated 
with six cycles of an R-CHOP regimen. He did not show any 
evidence of recurrence (normal gastroscopy and CT scan) at 36 
months of follow-up.
IVLBCL usually occurs in adults in the sixth and seventh decades. 
The tumor is often clinically unsuspected and can be easily 
overlooked on biopsy. The diagnosis is most commonly made 
at autopsy. The lymphoma cells are generally large with round 
nuclei and prominent nucleoli. The malignant cells uniformly 
express pan-B-cell antigens (CD20, CD79a) and variably express 
other antigens such as CD5 (38%) and CD10 (13%) [2]. There 
are no pathognomonic laboratory or radiologic abnormalities 
associated with IVLBCL. Abdominal CT and MRI findings of our 
patient with IVLBCL were nonspecific. What is the pathogenic 
mechanism for simultaneous presentation of gallbladder 
intravascular B-cell lymphoma with GIST? A unifying hypothesis 
supports a single underlying genetic instability that could have 
led to both diseases. The finding of two different neoplasms 
in our patient seems to be coincidental rather than related 
to the same pathogenic triggering. Central nervous system 
symptoms, skin manifestations, bone marrow involvement, 
and hemophagocytic syndrome are the most common clinical 
and laboratory abnormalities, but these were not seen in our 
case. Our patient presented with nonspecific symptoms and 
laboratory abnormalities. The ability of IVLBCL to involve any 
organ system further makes it very difficult to suspect this 
condition in a patient with a rare presentation such as ours.
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